A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis

Background. Sevelamer carbonate is an improved, buffered form of sevelamer hydrochloride developed for the treatment of hyperphosphataemia in CKD patients. Sevelamer carbonate formulated as a powder for oral suspension presents a novel, patient-friendly alternative to tablet phosphate binders. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Stanley, Ross, Calum, Mitra, Sandip, Kalra, Philip, Heaton, Jeremy, Hunter, John, Plone, Melissa, Pritchard, Nick
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Dialysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781155/
https://www.ncbi.nlm.nih.gov/pubmed/19666658
http://dx.doi.org/10.1093/ndt/gfp372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781155/
https://www.ncbi.nlm.nih.gov/pubmed/19666658
http://dx.doi.org/10.1093/ndt/gfp372

Ejemplares similares